Subscribe to Newsletter

Drug Discovery

Discovery & Development Drug Discovery

Trial Ready

The University of Oxford receives its first batch of AZD1222, a coronavirus vaccine candidate.
Discovery & Development Drug Discovery

ADCs on the Rise

How will the ADC sector fair in 2020 and beyond?
Business & Regulation Business Practice

Access Not Denied

| Stephanie Vine

When developing countermeasures against COVID-19, resource-poor settings should not be forgotten.
Discovery & Development Drug Discovery

Calming the Cytokine Storm

| Maryam Mahdi

How can salivary proteins derived from ticks help treat COVID-19?
Discovery & Development Drug Discovery

Going with Your Gut Instinct

| Stephanie Vine

Sitting Down With… Paul Peter Tak, President and CEO at Kintai Therapeutics.
Manufacture Technology and Equipment

Dimensions of Progress

| Maryam Mahdi

How far along is the pharmaceutical industry in its journey with 3D cell culture technologies?
Discovery & Development Drug Discovery

A Clearer (Chemical) Picture

| Maryam Mahdi

A new analytical technique could help in the production of purer pharmaceuticals.
Manufacture Drug Discovery

Let There Be Light

Using green light, a titanium catalyst could be a non-hazardous alternative to commonly used metal-based catalysts.
Discovery & Development Drug Discovery

Better Use Case

| Maryam Mahdi

Researchers are investigating the therapeutic value of immunotherapies for treating infectious diseases.
Discovery & Development Drug Discovery

Alleviating the Pressure

| Maryam Mahdi

A gene therapy could help prevent the symptoms of glaucoma.
Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register

December Issue of The Medicine Maker